ABBV Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 0.25%

Insider Buying (Last 12 Months): $0.00

Insider Selling (Last 12 Months): $130,132,002.24

AbbVie Insider Trading History Chart

AbbVie Share Price & Price History

^$193.57

▼ -0.72 (-0.37%)

As of 10/7/2024 01:00 AM ET

Days: 30 | 90 | 365

What The Recent Selloffs Really Mean

From Stansberry Research | Ad

There is nothing the Federal Reserve can do on September 18 to stop what's coming next for U.S. stocks.

Click here to view my new presentation now.

AbbVie Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
8/5/2024	Richard A. Gonzalez	Chairman	Sell	66,500	$186.52	$12,403,580.00	446,599
7/17/2024	Richard A. Gonzalez	Chairman	Sell	282,845	$175.00	$49,497,875.00	513,099
3/20/2024	Nicholas Donoghoe	EVP	Sell	21,082	$176.30	$3,716,756.60	55,903
3/18/2024	Jeffrey Ryan Stewart	EVP	Sell	58,949	$178.79	$10,539,491.71	60,941
2/29/2024	Kevin K Buckbee	SVP	Sell	5,144	$176.65	$908,687.60	6,983
2/29/2024	Perry C Siatis	EVP	Sell	9,891	$177.39	$1,754,564.49	10,397
2/29/2024	Robert A. Michael	COO	Sell	68,879	$176.45	$12,153,699.55	98,645
2/28/2024	Richard A. Gonzalez	CEO	Sell	138,616	$177.27	$24,572,458.32	519,099
2/23/2024	Perry C Siatis	EVP	Sell	13,753	$177.51	$2,441,295.03	28,173
2/23/2024	Scott T. Reents	CFO	Sell	14,140	$177.44	$2,509,001.60	27,065
2/21/2024	Azita Saleki-Gerhardt	EVP	Sell	52,870	$173.71	$9,184,047.70	243,944
12/26/2023	Nicholas Donoghoe	EVP	Sell	2,912	$154.72	$450,544.64	55,903
7/31/2023	Richard A. Gonzalez	CEO	Sell	18,500	$149.15	$2,759,275.00	625,294
4/25/2023	Elaine K. Sorg	SVP	Sell	6,130	$165.00	$1,011,450.00	35,330
4/17/2023	Elaine K. Sorg	SVP	Sell	7,499	$161.67	$1,212,363.33	35,330
4/3/2023	Elaine K. Sorg	SVP	Sell	15,002	$160.03	$2,400,770.06	42,829
4/3/2023	Perry C Siatis	EVP	Sell	3,520	$160.00	$563,200.00	10,377
3/13/2023	Jeffrey Ryan Stewart	EVP	Sell	53,125	$152.28	$8,089,875.00	60,941
3/1/2023	Elaine K. Sorg	SVP	Sell	15,003	$155.00	$2,325,465.00	42,829
3/1/2023	Perry C Siatis	EVP	Sell	12,135	$153.08	$1,857,625.80	10,377
3/1/2023	Scott T. Reents	CFO	Sell	15,942	$153.08	$2,440,401.36	809
2/21/2023	Carrie C. Strom	SVP	Sell	28,541	$151.04	$4,310,832.64	37,921
2/17/2023	Azita Saleki-Gerhardt	EVP	Sell	25,000	$149.53	$3,738,250.00	233,208
2/17/2023	Roxanne S. Austin	Director	Sell	10,000	$150.50	$1,505,000.00	40,705
12/12/2022	Timothy J. Richmond	EVP	Sell	42,370	$163.44	$6,924,952.80	13,837
5/23/2022	Michael Severino	Vice Chairman	Sell	79,801	$150.90	$12,041,970.90	152,103
5/16/2022	Henry O Gosebruch	EVP	Sell	83,960	$155.00	$13,013,800.00	16,623
5/16/2022	Michael Severino	Vice Chairman	Sell	100,000	$154.45	$15,445,000.00	152,103
5/9/2022	Michael Severino	Vice Chairman	Sell	100,000	$150.28	$15,028,000.00	152,103
5/6/2022	Michael Severino	Vice Chairman	Sell	100,000	$150.81	$15,081,000.00	152,103
3/24/2022	Jeffrey Ryan Stewart	EVP	Sell	27,690	$159.20	$4,408,248.00
3/9/2022	Brian L. Durkin	VP	Sell	18,628	$150.01	$2,794,386.28
3/1/2022	Henry O Gosebruch	EVP	Sell	15,000	$148.26	$2,223,900.00
3/1/2022	Robert A. Michael	Vice Chairman	Sell	43,105	$148.25	$6,390,316.25
2/7/2022	Carrie C. Strom	SVP	Sell	2,396	$141.17	$338,243.32
12/20/2021	Brian L. Durkin	VP	Sell	11,790	$128.51	$1,515,132.90
12/17/2021	Laura J. Schumacher	Vice Chairman	Sell	181,670	$130.24	$23,660,700.80
12/15/2021	Jeffrey Ryan Stewart	EVP	Sell	2,152	$128.00	$275,456.00
12/13/2021	Elaine K. Sorg	SVP	Sell	6,458	$125.85	$812,739.30
12/9/2021	Richard A. Gonzalez	CEO	Sell	174,100	$123.23	$21,454,343.00
12/6/2021	Timothy J. Richmond	EVP	Sell	50,350	$120.00	$6,042,000.00
11/2/2021	Roxanne S. Austin	Director	Sell	51,844	$116.38	$6,033,604.72

320 hedge funds just sold this stock

From Chaikin Analytics | Ad

320 hedge funds just sold this stock A strange force has seized control of Wall Street. Hedge funds are already moving their money… and preparing for even stranger days ahead. Over 320 hedge funds have quietly sold THIS famous stock – to prepare for a dramatic market shift

Get the strange truth from a 50-year Wall Street insider… including the name and ticker of the stock

SEC Filings (Institutional Ownership Changes) for AbbVie (NYSE:ABBV)

70.23% of AbbVie stock is owned by institutions. Institutional ownership can be a sign of analyst confidence in the fundamentals of the stock.

Institutional Buying and Selling by Quarter

AbbVie Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
10/7/2024	Fulton Bank N.A.	47,711	$9.42M	0.4%	-0.6%	0.003%
10/7/2024	Founders Capital Management	32,619	$6.44M	3.9%	-0.7%	0.002%
10/7/2024	McLean Asset Management Corp	3,423	$0.67M	0.2%	+17.5%	0.000%
10/7/2024	Parisi Gray Wealth Management	3,761	$0.74M	0.2%	+3.8%	0.000%
10/7/2024	MKT Advisors LLC	3,039	$0.60M	0.3%	-6.0%	0.000%
10/7/2024	Miracle Mile Advisors LLC	31,917	$6.30M	0.1%	+7.6%	0.002%
10/7/2024	Eagle Rock Investment Company LLC	5,872	$1.16M	0.2%	-2.7%	0.000%
10/7/2024	Consilio Wealth Advisors LLC	2,207	$0.44M	0.2%	+21.7%	0.000%
10/7/2024	Chemistry Wealth Management LLC	8,634	$1.71M	0.4%	-43.0%	0.000%
10/7/2024	Smith Anglin Financial LLC	3,777	$0.75M	0.1%	+6.7%	0.000%
10/7/2024	Lakeridge Wealth Management LLC	3,029	$0.60M	0.3%	-3.2%	0.000%
10/7/2024	Diversified Trust Co	39,966	$7.89M	0.2%	+9.1%	0.002%
10/7/2024	Davis Investment Partners LLC	9,281	$1.83M	0.8%	-1.3%	0.001%
10/7/2024	Azzad Asset Management Inc. ADV	24,065	$4.75M	0.5%	-1.0%	0.001%
10/7/2024	WealthBridge Capital Management LLC	12,256	$2.42M	0.7%	+8.6%	0.001%
10/7/2024	GAMMA Investing LLC	36,014	$7.11M	0.7%	+28.6%	0.002%
10/5/2024	Red Spruce Capital LLC	52,748	$10.42M	4.7%	-1.4%	0.003%
10/5/2024	Handelsbanken Fonder AB	1,145,941	$226.30M	0.9%	+1.5%	0.065%
10/5/2024	Grandview Asset Management LLC	18,047	$3.56M	2.0%	-0.9%	0.001%
10/5/2024	First International Bank & Trust	1,809	$0.36M	0.1%	+11.0%	0.000%
10/5/2024	waypoint wealth counsel	3,442	$0.68M	0.5%	+2.6%	0.000%
10/5/2024	Wright Investors Service Inc.	48,526	$9.58M	2.5%	+8.7%	0.003%
10/5/2024	Cullen Investment Group LTD.	13,515	$2.67M	0.4%	+1.6%	0.001%
10/5/2024	Bard Financial Services Inc.	24,430	$4.82M	1.0%	-67.3%	0.001%
10/5/2024	Burns J W & Co. Inc. NY	32,547	$6.43M	0.8%	-2.1%	0.002%
10/5/2024	Quent Capital LLC	8,866	$1.75M	0.2%	+1.1%	0.001%
10/5/2024	Collective Family Office LLC	6,587	$1.30M	0.4%	-3.6%	0.000%
10/5/2024	Arkansas Financial Group Inc.	1,595	$0.32M	0.0%	-7.0%	0.000%
10/5/2024	Inspirion Wealth Advisors LLC	202,312	$39.95M	5.6%	-2.3%	0.011%
10/5/2024	Harbor Investment Advisory LLC	22,331	$4.41M	0.4%	-2.4%	0.001%
10/5/2024	Mirador Capital Partners LP	52,607	$10.39M	1.9%	+1.9%	0.003%
10/5/2024	Eclectic Associates Inc. ADV	1,047	$0.21M	0.1%	N/A	0.000%
10/5/2024	Goelzer Investment Management Inc.	52,647	$10.40M	0.6%	-0.6%	0.003%
10/5/2024	Fluent Financial LLC	21,854	$4.32M	2.1%	-13.1%	0.001%
10/5/2024	Triton Wealth Management PLLC	1,376	$0.27M	0.2%	-4.1%	0.000%
10/4/2024	Ausdal Financial Partners Inc.	31,631	$6.25M	0.6%	-1.4%	0.002%
10/4/2024	jvl associates llc	1,101	$0.22M	0.1%	N/A	0.000%
10/4/2024	HBW Advisory Services LLC	7,214	$1.43M	0.2%	-8.1%	0.000%
10/3/2024	Rockland Trust Co.	35,284	$6.97M	0.3%	-23.1%	0.002%
10/3/2024	First Citizens Financial Corp	5,777	$1.14M	0.6%	+0.9%	0.000%
10/3/2024	Duncan Williams Asset Management LLC	4,260	$0.84M	0.5%	+135.9%	0.000%
10/3/2024	Abacus Wealth Partners LLC	1,737	$0.34M	0.1%	+14.9%	0.000%
10/3/2024	Capital Market Strategies LLC	10,590	$2.09M	1.3%	-0.9%	0.001%
10/3/2024	Apella Capital LLC	8,070	$1.59M	0.1%	+6.6%	0.000%
10/3/2024	Park Avenue Securities LLC	69,285	$13.68M	0.2%	-13.1%	0.004%
10/3/2024	Johnson & White Wealth Management LLC	6,116	$1.21M	1.0%	+4.1%	0.000%
10/3/2024	Alpha Omega Wealth Management LLC	55,011	$10.86M	2.0%	-2.7%	0.003%
10/3/2024	Canandaigua National Bank & Trust Co.	32,111	$6.34M	0.6%	-2.6%	0.002%
10/3/2024	Farmers Trust Co.	29,427	$5.81M	1.1%	-0.7%	0.002%
10/3/2024	Marotta Asset Management	1,780	$0.35M	0.1%	-2.9%	0.000%
10/3/2024	Pacific Wealth Management	40,256	$7.95M	3.7%	-0.4%	0.002%
10/3/2024	Curbstone Financial Management Corp	10,543	$2.08M	0.4%	-3.5%	0.001%
10/3/2024	Czech National Bank	359,823	$71.06M	0.7%	+6.9%	0.020%
10/3/2024	AMF Tjanstepension AB	44,446	$8.78M	0.1%	N/A	0.003%
10/2/2024	Central Pacific Bank Trust Division	13,782	$2.72M	0.3%	+19.6%	0.001%
10/2/2024	Whitcomb & Hess Inc.	1,776	$0.35M	0.1%	-3.3%	0.000%
10/2/2024	JLB & Associates Inc.	45,288	$8.94M	1.2%	-0.9%	0.003%
10/2/2024	Armstrong Henry H Associates Inc.	17,903	$3.54M	0.3%	-4.2%	0.001%
10/2/2024	Massmutual Trust Co. FSB ADV	192,075	$37.93M	1.1%	-1.0%	0.011%
10/2/2024	Trust Co. of Toledo NA OH	42,532	$8.40M	1.1%	+1.6%	0.002%
10/2/2024	Abacus Planning Group Inc.	2,212	$0.44M	0.1%	+50.6%	0.000%
10/2/2024	American National Bank & Trust	64,736	$12.78M	1.5%	-7.8%	0.004%
10/2/2024	M&R Capital Management Inc.	16,447	$3.25M	0.7%	+7.5%	0.001%
10/2/2024	Doliver Advisors LP	5,217	$1.03M	0.3%	-15.4%	0.000%
10/1/2024	Davis Capital Management	5,610	$1.11M	0.9%	-1.3%	0.000%
10/1/2024	Appleton Partners Inc. MA	40,592	$8.02M	0.6%	-2.9%	0.002%
10/1/2024	Jacobs & Co. CA	60,926	$12.03M	1.2%	-1.5%	0.003%
10/1/2024	Park National Corp OH	138,634	$27.38M	1.0%	-5.1%	0.008%
10/1/2024	Emprise Bank	2,132	$0.42M	0.2%	-30.8%	0.000%
10/1/2024	BancFirst Trust & Investment Management	3,401	$0.66M	0.2%	-16.3%	0.000%
10/1/2024	First Financial Bank Trust Division	25,093	$4.96M	0.5%	-3.8%	0.001%
10/1/2024	Neville Rodie & Shaw Inc.	100,915	$19.93M	1.5%	+5.4%	0.006%
9/30/2024	Mattson Financial Services LLC	6,751	$1.16M	0.4%	N/A	0.000%
9/23/2024	Centaurus Financial Inc.	7,120	$1.22M	0.1%	-2.9%	0.000%
9/20/2024	Anchor Investment Management LLC	86,189	$14.78M	1.5%	+0.8%	0.005%
9/18/2024	Sensible Money LLC	1,328	$0.23M	0.1%	-8.9%	0.000%
9/17/2024	University of Texas Texas AM Investment Management Co.	714	$0.12M	0.0%	-25.9%	0.000%
9/16/2024	Verity & Verity LLC	154,069	$26.43M	3.0%	+2.0%	0.009%
9/12/2024	American Trust	6,468	$1.11M	0.1%	-9.7%	0.000%
9/11/2024	Newbridge Financial Services Group Inc.	3,930	$0.67M	0.3%	-43.2%	0.000%
9/10/2024	Prio Wealth Limited Partnership	42,710	$7.33M	0.2%	-28.1%	0.002%
9/10/2024	Cannon Financial Strategists Inc.	4,107	$0.70M	0.1%	N/A	0.000%
9/9/2024	Heritage Wealth Management Inc.	24,421	$4.08M	1.4%	N/A	0.001%
9/9/2024	Lazari Capital Management Inc.	17,567	$3.01M	1.4%	-1.9%	0.001%
9/5/2024	Sanctuary Advisors LLC	427,347	$68.21M	0.5%	N/A	0.024%
9/3/2024	Clear Rock Advisors LLC	20,348	$3.49M	1.5%	+2.1%	0.001%
8/30/2024	Creekside Partners	1,957	$0.34M	0.2%	N/A	0.000%
8/30/2024	Brown Financial Advisors	4,222	$0.72M	0.3%	N/A	0.000%
8/30/2024	Strategic Investment Solutions Inc. IL	1,874	$0.33M	0.1%	N/A	0.000%
8/28/2024	Farmers National Bank	5,726	$0.98M	0.3%	-1.6%	0.000%
8/28/2024	Souders Financial Advisors	21,924	$3.76M	0.6%	+4.4%	0.001%
8/27/2024	Clearbridge Investments LLC	3,847,664	$659.95M	0.5%	-7.4%	0.218%
8/27/2024	Dana Investment Advisors Inc.	150,086	$25.74M	0.9%	+7.4%	0.008%
8/27/2024	KPP Advisory Services LLC	6,167	$1.06M	0.3%	+5.3%	0.000%
8/27/2024	New Century Financial Group LLC	7,705	$1.32M	0.6%	+342.6%	0.000%
8/26/2024	Wealthquest Corp	6,261	$1.07M	0.1%	+2.1%	0.000%
8/26/2024	Teachers Retirement System of The State of Kentucky	281,649	$48.31M	0.4%	-13.6%	0.016%
8/22/2024	Cetera Investment Advisers	610,223	$104.67M	0.2%	+0.3%	0.035%
8/22/2024	3Chopt Investment Partners LLC	13,030	$2.24M	0.7%	+20.7%	0.001%
8/21/2024	Heartland Bank & Trust Co	8,725	$1.50M	0.8%	+38.4%	0.000%

Data available starting January 2016

AbbVie Inc. discovers, develops, manufactures, and sells pharmaceuticals worldwide. The company offers Humira, an injection for autoimmune and intestinal Behçet's diseases, and pyoderma gangrenosum; Skyrizi to treat moderate to severe plaque psoriasis, psoriatic disease, and Crohn's disease; Rinvoq to treat rheumatoid and psoriatic arthritis, ankylosing spondylitis, atopic dermatitis, axial spondyloarthropathy, ulcerative colitis, and Crohn's disease; Imbruvica for the treatment of adult patients with blood cancers; Epkinly to treat lymphoma; Elahere to treat cancer; and Venclexta/Venclyxto to treat blood cancers. It also provides facial injectables, plastics and regenerative medicine, body contouring, and skincare products; botox therapeutic; Vraylar for depressive disorder; Duopa and Duodopa to treat advanced Parkinson's disease; Ubrelvy for the acute treatment of migraine in adults; and Qulipta for episodic and chronic migraine. In addition, the company offers Ozurdex for eye diseases; Lumigan/Ganfort and Alphagan/Combigan for the reduction of elevated intraocular pressure in patients with open angle glaucoma or ocular hypertension; Restasis to increase tear production; and other eye care products. Further, it provides Mavyret/Maviret to treat chronic hepatitis C virus genotype 1-6 infection; Creon, a pancreatic enzyme therapy; Lupron to treat advanced prostate cancer, endometriosis and central precocious puberty, and patients with anemia caused by uterine fibroids; Linzess/Constella to treat irritable bowel syndrome with constipation and chronic idiopathic constipation; and Synthroid for hypothyroidism. It has collaborations with Calico Life Sciences LLC; REGENXBIO Inc.; Janssen Biotech, Inc.; and Genentech, Inc., as well as collaboration with Tentarix Biotherapeutics, LP to develop conditionally-active and multi-specific biologics for oncology and immunology. The company was incorporated in 2012 and is headquartered in North Chicago, Illinois.

Today's Range

Now: $193.57

$192.84

$195.09

50 Day Range

MA: $193.35

$181.93

$199.35

52 Week Range

Now: $193.57

$135.85

$199.95

Volume

5,032,892 shs

Average Volume

5,334,974 shs

Market Capitalization

$341.82 billion

P/E Ratio

57.44

Dividend Yield

3.15%

Beta

0.63

Who are the company insiders with the largest holdings of AbbVie?: AbbVie's top insider investors include:
Richard A Gonzalez (CEO)
Richard A Gonzalez (Chairman)
Azita Saleki-Gerhardt (EVP)
Robert A Michael (COO)
Jeffrey Ryan Stewart (EVP)
Nicholas Donoghoe (EVP)
Elaine K Sorg (SVP)
Roxanne S Austin (Director)
Carrie C Strom (SVP)
Perry C Siatis (EVP)
Scott T Reents (CFO)
Timothy J Richmond (EVP)
Kevin K Buckbee (SVP)
Learn More about top insider investors at AbbVie.
Who are the major institutional investors of AbbVie?: AbbVie's top institutional shareholders include:
Handelsbanken Fonder AB — 0.06%
Czech National Bank — 0.02%
Inspirion Wealth Advisors LLC — 0.01%
Massmutual Trust Co. FSB ADV — 0.01%
Park National Corp OH — 0.01%
SG Americas Securities LLC — 0.00%
Learn More about top institutional investors of AbbVie stock.
Which major investors are selling AbbVie stock?: In the previous quarter, ABBV stock was sold by these institutional investors:
Bard Financial Services Inc.
Rockland Trust Co.
Park Avenue Securities LLC
Park National Corp OH
Chemistry Wealth Management LLC
American National Bank & Trust
Inspirion Wealth Advisors LLC
Oak Asset Management LLC
Within the previous year, company insiders that have sold AbbVie company stock include:
Richard A Gonzalez (CEO)
Richard A Gonzalez (Chairman)
Azita Saleki-Gerhardt (EVP)
Robert A Michael (COO)
Jeffrey Ryan Stewart (EVP)
Nicholas Donoghoe (EVP)
Elaine K Sorg (SVP)
Roxanne S Austin (Director)
Carrie C Strom (SVP)
Learn More investors selling AbbVie stock.
Which major investors are buying AbbVie stock?: In the previous quarter, ABBV stock was acquired by institutional investors including:
AMF Tjanstepension AB
Czech National Bank
Handelsbanken Fonder AB
GAMMA Investing LLC
Neville Rodie & Shaw Inc.
Wright Investors Service Inc.
Diversified Trust Co
Duncan Williams Asset Management LLC